Narong Ponsa, Jetsumon Sattabongkot, Pattamaporn Kittayapong, Nantana Eikarat, Russell E Coleman
Index: Am. J. Trop. Med. Hyg. 69(5) , 542-7, (2003)
Full Text: HTML
The sporontocidal activity of tafenoquine (WR-238605) and artelinic acid was determined against naturally circulating isolates of Plasmodium vivax in western Thailand. Primaquine was used as a negative control and a dihydroacridine-dione (WR-250547) was used as a positive control. Laboratory-reared Anopheles dirus mosquitoes were infected with P. vivax by allowing mosquitoes to feed on blood (placed in an artificial-membrane feeding apparatus) collected from gametocytemic volunteers reporting to local malaria clinics in Tak province, Thailand. Four days post-infection, mosquitoes were refed on uninfected mice treated 90 minutes earlier with a given drug. Drug activity was determined by assessing oocyst and sporozoite development. Neither primaquine nor artelinic acid affected oocyst or sporozoite development at a dose of 100 mg of base drug/kg of mouse body weight. In contrast, tafenoquine and WR-250547 affected sporogonic development at doses as low as 25.0 and 0.39 mg/kg, respectively. The potential role of these compounds in the prevention of malaria transmission is discussed, as are alternative strategies for the use of transmission-blocking antimalarial drugs.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Tafenoquine (Succinate)
CAS:106635-81-8 |
C28H34F3N3O7 |
Uptake of the antileishmania drug tafenoquine follows a ster...
2011-11-01 [J. Antimicrob. Chemother. 66(11) , 2562-5, (2011)] |
Military aviators, special operations forces, and causal mal...
2003-12-01 [Mil. Med. 168(12) , 1001-6, (2003)] |
A randomized, double-blind, safety and tolerability study to...
2009-08-01 [Am. J. Trop. Med. Hyg. 81(2) , 356-62, (2009)] |
In-vitro interaction of tafenoquine and chloroquine in Plasm...
2003-01-01 [Wien. Klin. Wochenschr. 115 Suppl 3 , 28-32, (2003)] |
Risk factors for gametocyte carriage in uncomplicated falcip...
2011-01-01 [Chemotherapy 57(6) , 497-504, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved